PATENT CLAIM ANALYSIS

Application Number: 15969147
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "393000"]

Abstract:
Described herein, inter alia, are compounds useful for the prevention or treatment of hyperproliferative diseases or disorders.

Claim (Index 50):
The method of  claim 49 , wherein the hyperproliferative disorder is (a) prostate cancer, or (b) hormone sensitive prostate cancer, or (c) hormone refractory prostate cancer.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 93.0
- Lexical Diversity: 1.11111
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13615085', '14318234', '12294881', '15181030', '11066373']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7864044702878424
- 35 USC 102 Novelty (BERT): 0.5735113321744228
- Combined Prediction Score: 0.7651151564765004
- Mean Citation Score: 410.387442
- Max Citation Score: 501.15558
- Similarity Product: 335.32202686224457

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test